Epithelial cytoprotection sustains ectopic expression of tissue-restricted antigens in the thymus during murine acute GVHD

Blood

Volumn 122, Issue 5, 2013, Pages 837-841

  Dertschnig, Simone ^a   Nusspaumer, Gretel ^a   Ivanek, Robert ^a   Hauri Hohl, Mathias M ^b   Holländer, Georg A ^a,c   Krenger, Werner ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOIMMUNE REGULATOR PROTEIN; KERATINOCYTE GROWTH FACTOR; TISSUE RESTRICTED ANTIGEN; TRANSCRIPTOME; UNCLASSIFIED DRUG; AUTOANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALGORITHM; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CELL LOSS; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; ECTOPIC EXPRESSION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOLOGICAL TOLERANCE; MARKOV CHAIN; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMOCYTE; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DBA MOUSE; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; THYMUS; TRANSGENIC MOUSE;

ACUTE DISEASE; ANIMALS; ANTIGENS; AUTOANTIGENS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GRAFT VS HOST DISEASE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; THYMUS GLAND;

EID: 84886394447     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-474759     Document Type: Article

References (24)

1. Vicente R, Swainson L, Marty-Grès S, et al. Molecular and cellular basis of T cell lineage commitment. Semin Immunol. 2010;22(5): 270-275.
2. Klein L, Hinterberger M, Wirnsberger G, Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat Rev Immunol. 2009;9(12):833-844.
3. Anderson MS, Su MA. Aire and T cell development. Curr Opin Immunol. 2011;23(2): 198-206.
4. Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 2002;51(5): 1383-1390.
5. Liston A, Gray DH, Lesage S, et al. Gene dosage—limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med. 2004;200(8):1015-1026.
6. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012;12(6):443-458.
7. Na IK, Lu SX, Yim NL, et al. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease. J Clin Invest. 2010;120(1):343-356.
8. Krenger W, Blazar BR, Holländer GA. Thymic T-cell development in allogeneic stem cell transplantation. Blood. 2011;117(25): 6768-6776.
9. Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med. 2008;57(4): 177-183.
10. Holländer GA, Widmer B, Burakoff SJ. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol. 1994;152(4):1609-1617.
11. van den Brink MR, Moore E, Ferrara JL, Burakoff SJ. Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation. 2000; 69(3):446-449.
12. Zhang Y, Hexner E, Frank D, Emerson SG. CD41 T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease. J Immunol. 2007;179(5):3305-3314.
13. Sakoda Y, Hashimoto D, Asakura S, et al. Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood. 2007;109(4): 1756-1764.
14. Hauri-Hohl MM, Keller MP, Gill J, et al. Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation. Blood. 2007;109(9): 4080-4088.
15. Rossi S, Blazar BR, Farrell CL, et al. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood. 2002;100(2): 682-691.
16. Rossi SW, Jeker LT, Ueno T, et al. Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells. Blood. 2007;109(9):3803-3811.
17. Zuklys S, Mayer CE, Zhanybekova S, et al. MicroRNAs control the maintenance of thymic epithelia and their competence for T lineage commitment and thymocyte selection. J Immunol. 2012;189(8):3894-3904.
18. Gillard GO, Farr AG. Features of medullary thymic epithelium implicate postnatal development in maintaining epithelial heterogeneity and tissue-restricted antigen expression. J Immunol. 2006; 176(10):5815-5824.
19. Gray DH, Fletcher AL, Hammett M, et al. Unbiased analysis, enrichment and purification of thymic stromal cells. J Immunol Methods. 2008; 329(1-2):56-66.
20. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002; 298(5597):1395-1401.
21. Derbinski J, Gäbler J, Brors B, et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J Exp Med. 2005; 202(1):33-45.
22. Gray DH, Seach N, Ueno T, et al. Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood. 2006;108(12): 3777-3785.
23. Hubert FX, Kinkel SA, Webster KE, et al. A specific anti-Aire antibody reveals aire expression is restricted to medullary thymic epithelial cells and not expressed in periphery. J Immunol. 2008;180(6): 3824-3832.
24. Hess AD. Equal opportunity targeting in chronic GVHD. Blood. 2012;119(26):6183-6184.